Cancer Immunotherapy Month | Dr. E. John Wherry's

E. John Wherry, PhD, Associate Director of the CRI Scientific Advisory Council, delves into the pivotal role of scientific research and discovery in revolutionizing cancer immunotherapy. Dr. Wherry passionately explains how cutting-edge research is unlocking new, life-saving treatments, offering hope to millions battling cancer.
--
Established in 1953, the Cancer Research Institute (CRI) is a 501(c)(3) nonprofit organization dedicated to harnessing our immune system’s power to control and potentially cure all cancers. Our mission: Save more lives by fueling the discovery and development of powerful immunotherapies for all types of cancer. To accomplish this, we rely on donor support and collaborative partnerships to fund and carry out the most innovative clinical and laboratory research around the world, support the next generation of the field’s leaders, and serve as the trusted source of information on immunotherapy for cancer patients and their caregivers. www.cancerrese...
Cancer Research Institute is a registered 501(c)(3) nonprofit under EIN 13-1837442. Donations are tax-deductible to the fullest extent allowable under the law.